These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 121071)

  • 21. [Irreversible changes in cytochrome P-420 differential spectrum amplitude in microsomal membranes. New properties of Cu(II)-EDTA complex].
    Lemeshko VV; Sukhodub AL
    Ukr Biokhim Zh (1978); 1997; 69(2):120-5. PubMed ID: 9463230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of inducers of cytochrome P-450 on the metabolism of [3-14C]coumarin by rat hepatic microsomes.
    Peters MM; Walters DG; van Ommen B; van Bladeren PJ; Lake BG
    Xenobiotica; 1991 Apr; 21(4):499-514. PubMed ID: 1897250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of cytochrome P-450IIB1 as a cocaine-bioactivating isoform in rat hepatic microsomes and in cultured rat hepatocytes.
    Boelsterli UA; Lanzotti A; Göldlin C; Oertle M
    Drug Metab Dispos; 1992; 20(1):96-101. PubMed ID: 1347004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effects of the medicinal herb, Thonningia sanguinea, on liver drug metabolizing enzymes of rats.
    Gyamfi MA; Hokama N; Oppong-Boachie K; Aniya Y
    Hum Exp Toxicol; 2000 Nov; 19(11):623-31. PubMed ID: 11211240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of "drugs for liver disease" on hepatotoxic action of carbon tetrachloride. II. Effect of protoporphyrin and phosphorylcholine on microsomal drug-metabolizing enzyme activities and the components in injuried liver.
    Ogiso T; Kobayashi T; Kuhara K; Kato Y
    Jpn J Pharmacol; 1975 Aug; 25(4):411-21. PubMed ID: 813044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of the oral contraceptive, menstranol, on drug-metabolizing enzymes of female rats in thiamin-supplemented and deficiency states.
    Wade AE; Evans JL; Seitz A
    Pharmacology; 1976; 14(2):104-14. PubMed ID: 822434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism of n-hexane by rat liver and extrahepatic tissues and the effect of cytochrome P-450 inducers.
    Crosbie SJ; Blain PG; Williams FM
    Hum Exp Toxicol; 1997 Mar; 16(3):131-7. PubMed ID: 9088965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cadmium administration and hepatic drug metabolizing enzyme system: effect of pretreatment with phenobarbital and 3-methyl cholanthrene.
    Mgbodile MU
    Biochem Int; 1983 Jan; 6(1):11-20. PubMed ID: 6679315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of cytochrome p450 inhibition by cimetidine on the warm hepatic ischemia-reperfusion injury in rats.
    Shaik IH; Mehvar R
    J Surg Res; 2010 Apr; 159(2):680-8. PubMed ID: 19500799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of curcumin, capsaicin, and piperine on the rat liver drug-metabolizing enzyme system in vivo and in vitro.
    Suresh D; Srinivasan K
    Can J Physiol Pharmacol; 2006 Dec; 84(12):1259-65. PubMed ID: 17487234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of ascorbic acid on the hepatic cytochrome P-450, and glutathione in guinea-pigs exposed to 2,4-dichlorophenol.
    Nagyová A; Ginter E
    Physiol Res; 1995; 44(5):301-5. PubMed ID: 8869264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amlodipine inhibits rat microsomal cytochrome P450-mediated drug biotransformation.
    Drobitch RK; McLellan RA; Renton KW
    J Pharm Sci; 1997 Dec; 86(12):1501-3. PubMed ID: 9423169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triphenyltin acetate-mediated in vitro inactivation of rat liver cytochrome P-450.
    Nebbia C; Ceppa L; Dacasto M; Carletti M
    J Toxicol Environ Health A; 1999 Mar; 56(6):433-47. PubMed ID: 10096365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Denitrosation of the anti-cancer drug 1,3-bis(2-chloroethyl)-1-nitrosourea catalyzed by microsomal glutathione S-transferase and cytochrome P450 monooxygenases.
    Weber GF; Waxman DJ
    Arch Biochem Biophys; 1993 Dec; 307(2):369-78. PubMed ID: 8274024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel glutathione conjugate of flutamide in incubations with human liver microsomes.
    Kang P; Dalvie D; Smith E; Zhou S; Deese A
    Drug Metab Dispos; 2007 Jul; 35(7):1081-8. PubMed ID: 17403914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enzymatic formation of chemically reactive metabolites of N-nitrosodesmethyl tripelennamine by a mechanism other than N-dealkylation.
    Rao GS; Krishna G; Gillette JR
    Biochem Pharmacol; 1975 Sep; 24(18):1707-11. PubMed ID: 1191328
    [No Abstract]   [Full Text] [Related]  

  • 37. Preliminary carcinogenic and cocarcinogenic studies on captan following topical exposure in mice.
    Antony M; Shukla Y; Mehrotra NK
    Bull Environ Contam Toxicol; 1994 Feb; 52(2):203-11. PubMed ID: 8123979
    [No Abstract]   [Full Text] [Related]  

  • 38. Protective effect of glutathione on the in vitro inhibition of hepatic cytochrome P-450 by captan.
    Dalvi RR; Ashley WM
    Drug Chem Toxicol; 1979; 2(3):245-55. PubMed ID: 121071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toxicologic studies of N-trichloromethylthio-4-cyclohexene-1,2-dicarboximide (captan): its metabolism by rat liver drug-metabolizing enzyme system.
    Peeples A; Dalvi RR
    Toxicology; 1978 Apr; 9(4):341-51. PubMed ID: 663942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of glutathione in the reduction of captan-induced in vivo inhibition of monooxygenases and liver toxicity in the rat.
    Dalvi RR
    J Environ Sci Health B; 1988 Apr; 23(2):171-8. PubMed ID: 3385136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.